Vivanza -Drug Insights, 2016 Now Available at iData Insights
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Vivanza</strong> -<strong>Drug</strong> <strong>Insights</strong>, <strong>2016</strong> <strong>Now</strong> <strong>Available</strong> <strong>at</strong> iD<strong>at</strong>a<br />
<strong>Insights</strong><br />
DelveInsight <strong>Drug</strong> Report, <strong>Vivanza</strong>- <strong>Drug</strong> <strong>Insights</strong>, <strong>2016</strong>highlights the <strong>Vivanza</strong> marketed details, pipeline<br />
st<strong>at</strong>us and the Global API Manufacturers along with the loc<strong>at</strong>ion. The Delve<strong>Insights</strong> report covers the<br />
Global Market Assessment of the <strong>Vivanza</strong> covering the total sales estim<strong>at</strong>ion and also provides the<br />
<strong>Vivanza</strong> sales performance during the historical period and forecast period to 2018. Delve<strong>Insights</strong> Report<br />
also covers the detailed clinical assessment of <strong>Vivanza</strong>, p<strong>at</strong>ents inform<strong>at</strong>ion and exclusivity d<strong>at</strong>a, route<br />
of synthesis, competitive landscape, and generic players. In addition to this, Delve<strong>Insights</strong> Report<br />
provides the SWOT analysis for the <strong>Vivanza</strong>. Please note:This report requires certain upd<strong>at</strong>es. We have<br />
all the inform<strong>at</strong>ion available but require 3 business days to complete the process and ensure it is as upto-d<strong>at</strong>e<br />
as possible. Certain sections in the report may be removed or altered based on the availability<br />
and relevance of d<strong>at</strong>a for the indic<strong>at</strong>ed drug.<br />
Browse Complete Report with TOC @ http://www.id<strong>at</strong>ainsights.com/reports-landingpage.php?id=165849/vivanza-drug-insights-<strong>2016</strong><br />
To Get Sample Copy of Report visit http://www.id<strong>at</strong>ainsights.com/reports-landingpage.php?id=165849/vivanza-drug-insights-<strong>2016</strong><br />
Table of Contents<br />
1. DelveInsight Report Introduction<br />
2. <strong>Vivanza</strong> Overview<br />
2.1 Market Competition<br />
2.3 Competitors in Development<br />
3 Global Sales Assessment<br />
3.1 Historical Sales of Somavert<br />
3.2 Forecasted Sales of Somavert<br />
4 Product Description<br />
4.1 Mechanism of Action<br />
4.2 Pharmacodynamic Properties<br />
4.3 Pharmacokinetic Properties<br />
5 Marketed Details<br />
1
5.1 United St<strong>at</strong>es<br />
5.2 Europe<br />
6 P<strong>at</strong>ent Inform<strong>at</strong>ion<br />
6.1 P<strong>at</strong>ent Numbers and Expiry Details<br />
6.2 P<strong>at</strong>ent and Exclusivity Expiry Assessment United St<strong>at</strong>es (US)<br />
6.3 P<strong>at</strong>ent Details<br />
7 Route of Synthesis<br />
8 Global API Manufacturers Assessment<br />
8.1 The United St<strong>at</strong>es <strong>Drug</strong> Master File (US DMF)<br />
8.2 The Europe <strong>Drug</strong> Master File (EUDMF)/Active Substance Master File (ASMF)<br />
8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China<br />
8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India<br />
9 Generic Players<br />
10 The Pipeline Coverage<br />
11 Clinical Trials Inform<strong>at</strong>ion<br />
11.1 Clinical Trials by Zone<br />
12 Company Profile<br />
12.1 Company Summary<br />
12.2 Company Financials<br />
13 SWOT Analysis<br />
14 References<br />
15 Appendix<br />
16 Methodology<br />
2
17 Consulting Services<br />
18 About DelveInsight<br />
19 Contact Us<br />
20 Disclaimer<br />
Read More http://www.id<strong>at</strong>ainsights.com/reports-landing-page.php?id=165849/vivanza-drug-insights-<br />
<strong>2016</strong><br />
About Us:<br />
iD<strong>at</strong>a <strong>Insights</strong> which oper<strong>at</strong>es under Precision Research and Consulting Priv<strong>at</strong>e Limited is a leading<br />
market research inform<strong>at</strong>ion aggreg<strong>at</strong>or and marketing research consulting firm. We conduct both<br />
primary and secondary research. Our work does not end with research it is also involved in distributing<br />
reports for different companies . We provide actionable recommend<strong>at</strong>ions and provide our expertise for<br />
business success today and tomorrow. It is our goal to be a partner to our clients in the explor<strong>at</strong>ion and<br />
discovery, and then be their guide in the implement<strong>at</strong>ion of changes th<strong>at</strong> will make a difference to their<br />
bottom line.<br />
ContactUs:<br />
iD<strong>at</strong>a <strong>Insights</strong><br />
Tel: 1-866-237-2965<br />
Web: http://www.id<strong>at</strong>ainsights.com<br />
Email: info@id<strong>at</strong>ainsights.com<br />
About iD<strong>at</strong>a <strong>Insights</strong><br />
We work around the clock until our clients are completely s<strong>at</strong>isfied with their promised results. It is our<br />
mission to provide timely services coupled with acute client care to cre<strong>at</strong>e a long-lasting rel<strong>at</strong>ionship<br />
with you. We deliver on our promise to provide results th<strong>at</strong> are essential to the success of your<br />
company. We believe th<strong>at</strong> by doing so, we will earn the trust of our clients for future project.<br />
3
Change language